SA biotech buys Birmingham company

CytoBioscience CEO James Garvin said the acquisition of BioDtech is a big win for his San Antonio-based ...

SA biotech CEO: Company on the verge of taking cancer-detection product to market

Seno Medical Instruments Inc. CEO Tom Umbel said the company is picking up momentum. GABE HERNANDEZ | ...


BioMed SA Annual Breakfast Meeting

When: 7:30-9:30 AM Tuesday, December 18, 2018 Where: Omni Hotel, 9821 Colonnade Blvd. Join ...
San Antonio biotech acquired by New Jersey medical device marketer
July 5, 2017

NuPak Medical's David Cocke said Katena Products' talks about acquiring the San Antonio biotech company began in late January. Courtesy of Bibb Gault 

By W. Scott Bailey, Reporter/Project Coordinator, San Antonio Business Journal

NuPak Medical Ltd. will remain in the Alamo City where it was founded 20 years ago.

San Antonio-based NuPak Medical Ltd. has new ownership.

Katena Products, which markets precision ophthalmic instruments, biologics and medical devices to hospitals, surgical centers and other providers across the world, has purchased the 20-year-old Alamo City company.

David Cocke, who co-founded NuPak Medical with Dr. Jerre Freeman and Curtis Freeman out of a 7,700-square-foot production facility in North San Antonio in 1997, would not disclose the terms of the sale. But he did tell me the company will remain in the Alamo City, where it expects to add more personnel.

"Katena is our largest customer as a contract manufacturer and wants use our San Antonio operations as a platform for other new product introductions to drive future growth," Cocke said.

NuPak is an FDA-registered company that provides contract manufacturing services - including product assembly and packaging, as well as injection molding work - to the medical device industry. It has dealt with clients in several medical specialties.

The deal with Katena has come together relatively quickly.

"We started the discussions in late January," said Cocke, who will serve as vice president of manufacturing for Katena's San Antonio operations."Katena has been in an acquisition mode. It made since to integrate."

The deal could provide NuPak Medical greater stability. One of the key elements of the transaction is an extended lease for the company's current facility, where Cocke said there will be room for brick-and-mortar expansion to accommodate more growth opportunities.

Katena currently markets a comprehensive line of medical products to customers in more than 110 countries. The company is owned by Audax Private Equity, a Boston-based firm that has more than $10 billion in assets under management.

Katena CEO Mark Fletcher said the acquisition of NuPak Medical will strengthen the New Jersey company's manufacturing and product development capabilities.

Courtesy of Bibb Gault NuPak Medical's David Cocke said Katena Products' talks about acquiring the San Antonio biotech company began in late January.

"They are excited about being in San Antonio," Cocke said.

NuPak Medical's new ownership has wasted little time exploring collaborative opportunities in San Antonio.


Stay informed. Subscribe to BioMed SA news alerts.